Quarterly Report • Aug 3, 2023
Quarterly Report
Open in ViewerOpens in native device viewer
| 1. Interim management report | |
|---|---|
| 3. Condensed consolidated statement of comprehensive income | |
| 4. Condensed consolidated statement of financial position | |
| 5. Condensed consolidated statement of changes in equity | |
| 6. Condensed consolidated cash flow statement | |
| 7. Notes to the interim financial information | |
| 8. Other operating income | |
| 9. Services and other goods | |
| $11. \;Non-recurring result. \label{prop:non-1} \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots$ | |
| 12. Segment information | |
| . 13. Goodwill…………………………………………………………………………………………… |
|
| 14. Debt ……………………………………………………………………………………………… | |
| 16. Total adjustments for non-cash items | |
| 17. Total changes in working capital | |
| 18. Business combination | |
| 19. Related parties | |
| 20. Subsequent events | |
| 21. Effective tax rate | |
| 22. Alternative performance measures |
The undersigned hereby declare that, to the best of their knowledge, the condensed consolidated financial statements for the six-month period ended 30 June 2023, which have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit and loss of the company and the undertakings included in the consolidation as a whole, and that the interim management report includes a fair review of the important events that have occurred during the first semester of the financial year and of other legal necessary information.
Rafael Padilla, CEO Karin de Jong, CFO
A detailed report on the development in the first six months of 2023 can be found in Fagron's press release of 3 August 2023.
| (x 1,000 euros) | Note | June 2023 | June 2022 |
|---|---|---|---|
| Operating income | 372,456 | 331,221 | |
| Revenue | 371,573 | 328,565 | |
| Other operating income | 8 | 882 | 2,656 |
| Operating expenses | 319,727 | 284,419 | |
| Trade goods | 145,973 | 138,199 | |
| Services and other goods | 9 | 62,712 | 54,033 |
| Employee benefit expenses | 90,674 | 74,030 | |
| Depreciation and amortization | 18,958 | 15,720 | |
| Other operating expenses | 1,410 | 2,437 | |
| Operating profit | 52,728 | 46,801 | |
| Financial income | 14 | 2,465 | 5,130 |
| Financial expenses | 14 | -13,011 | -7,316 |
| Profit before income tax | 42,182 | 44,615 | |
| Taxes | 21 | 8,901 | 9,317 |
| Net-profit (loss) | 33,282 | 35,299 | |
| Attributable to: | |||
| Shareholders of the company (net profit) | 33,037 | 35,166 | |
| Non-controlling interest(s) | 244 | 132 | |
| Profit (loss) per share attributable to the shareholders during the period |
|||
| Profit (loss) per share (in euros) | 10 | 0.45 | 0.48 |
| Diluted profit (loss) per share (in euros) | 10 | 0.45 | 0.48 |
| (x 1,000 euros) | Note | June 2023 | June 2022 |
|---|---|---|---|
| Net profit (loss) for the period | 33,282 | 35,299 | |
| Other comprehensive income: | |||
| Items that may be subsequently reclassified to profit or loss | |||
| Interest hedge | 14 | 962 | 2,744 |
| Currency translation differences | 11,166 | 26,927 | |
| Other comprehensive income for the period | 12,128 | 29,672 | |
| Total comprehensive income for the period | 45,409 | 64,970 | |
| Attributable to: | |||
| Shareholders of the company | 45,215 | 64,813 | |
| Non-controlling interest(s) | 195 | 158 |
The unrealized currency translation differences of 11.2 million euros in the first six months of 2023 are mainly due to the strengthening of the Brazilian real against the euro at 31 December 2022.
The unrealized currency translation differences in the first six months of 2022 of 26.9 million euros were mainly due to the strengthening of the Brazilian real against the euro at 31 December 2021.
| (x 1,000 euros) | Note | June 2023 | December 2022 |
|---|---|---|---|
| Non-current assets | 668,727 | 653,000 | |
| Goodwill | 13 | 437,396 | 429,768 |
| Intangible assets | 40,232 | 33,633 | |
| Property, plant and equipment | 111,262 | 104,086 | |
| Leasing and similar rights | 37,745 | 39,510 | |
| Financial assets | 4,252 | 4,210 | |
| Financial Instruments | 7,455 | 13,277 | |
| Other non-current fixed assets | 3,651 | 3,731 | |
| Deferred tax assets | 26,735 | 24,785 | |
| Current assets | 355,991 | 318,010 | |
| Inventories | 127,161 | 108,337 | |
| Trade receivables | 76,965 | 60,722 | |
| Financial instruments | 6,808 | 451 | |
| Other receivables | 32,844 | 23,163 | |
| Cash and cash equivalents | 112,213 | 125,337 | |
| Total assets | 1,024,719 | 971,010 | |
| Equity | 440,526 | 410,518 | |
| Shareholders' equity (parent) | 436,372 | 404,541 | |
| Non-controlling interest(s) | 4,155 | 5,977 | |
| Non-current liabilities | 383,396 | 389,484 | |
| Provisions | 2,208 | 2,024 | |
| Pension obligations | 2,719 | 2,739 | |
| Deferred tax liabilities | 2,694 | 4,352 | |
| Debt | 14 | 344,509 | 346,673 |
| Lease Liabilities | 31,266 | 33,697 | |
| Current liabilities | 200,796 | 171,009 | |
| Debt | 14 | 11 | 9,461 |
| Lease liabilities | 9,712 | 9,548 | |
| Trade payables | 119,318 | 97,856 | |
| Tax liabilities for the current year | 9,895 | 7,993 | |
| Other current taxes, remuneration and social security | 36,377 | 30,777 | |
| Other current payables | 18 | 24,126 | 15,191 |
| Financial instruments | 1,357 | 181 | |
| Total liabilities | 584,192 | 560,493 | |
| Total equity and liabilities | 1,024,719 | 971,010 |
| (x 1,000 euros) | Share capital & share premium |
Other reserves |
Cash flow hedge reserve |
Treasury shares |
Retained earnings |
Total | Non control ling interest |
Total equity |
|---|---|---|---|---|---|---|---|---|
| Balance as of 1 January 2022 |
520,785 | -277,154 | -18,823 | 95,297 | 320,105 | 5,361 | 325,466 | |
| Profit (loss) for the period | 35,166 | 35,166 | 132 | 35,299 | ||||
| Other comprehensive income | 29,647 | 29,647 | 25 | 29,672 | ||||
| Total comprehensive income for the period |
29,647 | 35,166 | 64,813 | 158 | 64,970 | |||
| Capital increase | 453 | 453 | 453 | |||||
| Declared dividends | -14,592 | -14,592 | -14,592 | |||||
| Share-based payments | 1,079 | 1,079 | 1,079 | |||||
| Balance as of 30 June 2022 | 521,238 | -246,428 | -18,823 | 115,872 | 371,859 | 5,519 | 377,377 | |
| Profit (loss) for the period | 34,445 | 34,445 | 322 | 34,767 | ||||
| Other comprehensive income | -9,868 | 7,384 | -2,484 | 136 | -2,347 | |||
| Total comprehensive income for the period |
-9,868 | 7,384 | 34,445 | 31,962 | 458 | 32,420 | ||
| Capital increase | ||||||||
| Declared dividends | ||||||||
| Share-based payments | 720 | 720 | ||||||
| Balance as of 31 December 2022 |
521,238 | -255,576 | 7,384 | -18,823 | 150,317 | 404,541 | 5,977 | 410,518 |
| Profit (loss) for the period | 33,037 | 33,037 | 244 | 33,282 | ||||
| Other comprehensive income | 11,215 | 962 | 12,177 | -50 | 12,128 | |||
| Total comprehensive income for the period |
11,215 | 962 | 33,037 | 45,215 | 195 | 45,409 | ||
| Capital increase | 3,293 | 3,293 | 3,293 | |||||
| Declared dividends | -18,175 | -18,175 | -18175 | |||||
| Share-based payments | 1,232 | 1,232 | 1,232 | |||||
| Acquisition of non-controlling interests |
266 | 266 | -2,017 | -1,751 | ||||
| Balance as of 30 June 2023 | 524,531 | -242,862 | 8,346 | -18,823 | 165,180 | 436,372 | 4,155 | 440,526 |
| (x 1,000 euros) Note |
June 2023 | June 2022 | |
|---|---|---|---|
| Operating activities | |||
| Profit before income taxes | 42,182 | 44,615 | |
| Taxes paid | -11,189 | -8,731 | |
| Adjustments for financial items | 10,546 | 2,186 | |
| Total adjustments for non-cash items | 16 | 20,058 | 16,139 |
| Total changes in working capital | 17 | -18,322 | -15,622 |
| Total cash flow from operating activities | 43,275 | 38,587 | |
| Investment activities | |||
| Capital expenditure | -20,984 | -6,681 | |
| Investments in existing shareholdings (subsequent payments) and in new holdings |
-5,542 | -46,638 | |
| Proceeds from sold shareholdings | 3,226 | ||
| Total cash flow from investment activities | -26,526 | -50,094 | |
| Financing activities | |||
| Capital increase | 3,293 | 453 | |
| Dividends paid | -13,086 | -9,955 | |
| New debt | 135,000 | ||
| Reimbursement of debt | -10,437 | -65,122 | |
| Payment of lease obligations | -5,743 | -4,523 | |
| Interest received | 2,893 | 990 | |
| Interest paid | -9,456 | -6,013 | |
| Total cash flow from financing activities | -32,535 | 50,830 | |
| Total net cash flow for the period | -15,787 | 39,323 | |
| Cash and cash equivalents – start of the period | 125,337 | 70,646 | |
| Gains (losses) from currency translation differences | 2,662 | 4,026 | |
| Cash and cash equivalents – end of the period | 112,213 | 113,996 | |
| Changes in cash and cash equivalents | -15,787 | 39,323 |
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.
The Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. Fagron's operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
These condensed consolidated financial statements were approved for publication by the Board of Directors on 1 August 2023.
In the event of differences between the English translation and the Dutch original of the interim financial statements, the latter prevails.
This condensed consolidated interim financial information for the first six months of 2023, including the comparative figures for 2022, has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union. The condensed consolidated interim financial information must be read in conjunction with the 2022 annual report (including the principles for financial reporting) which is available at www.fagron.com.
The most important accounting policies used to prepare the condensed consolidated interim financial statements for the first semester of 2023 are consistent with those applied in the Fagron consolidated financial statements for the year ended 31 December 2022.
A summary of the most important accounting policies can be found in the 2022 annual report. The annual report can be consulted on www.fagron.com.
This condensed consolidated interim financial information has been prepared in accordance with IFRS standards and IFRIC interpretations that apply, or which are applied early, as of 30 June 2023 and which have been endorsed by the European Union.
Standards and interpretations applicable for the annual period beginning on or after 1 January 2023
• Amendments to IAS 12 Income taxes: International Tax Reform – Pillar Two Model Rules (effective immediately but not yet endorsed in the EU – disclosures are required for annual periods beginning on or after 1 January 2023)
Standards and interpretations published, but not yet applicable for the annual period beginning on 1 January 2023:
Fagron has determined that the application of these changes to these standards does not have any material effect on these interim financial statements.
Revenue and operating profit of Fagron are limitedly impacted by seasonal influences.
Decrease of other operating income is mainly due to a release of contingent obligations in 2022 related to acquisitions in North America.
| (x 1,000 euros) | June 2023 | June 2022 |
|---|---|---|
| Sales and distribution costs | 21,269 | 20,188 |
| Contracted services | 16,025 | 13,316 |
| Other services and goods | 25,417 | 20,529 |
| Total services and other goods | 62,712 | 54,033 |
Other services and goods cover a wide range of services and goods such as maintenance, utilities, office supplies and travel costs.
| (x 1 euro) | June 2023 | June 2022 |
|---|---|---|
| Basic profit (loss) per share | 0.45 | 0.48 |
| Diluted profit (loss) per share | 0.45 | 0.48 |
| (x 1,000 euros) | June 2023 | June 2022 |
|---|---|---|
| Profit (loss) attributable to the shareholders of the company | 33,037 | 35,166 |
The weighted average number of ordinary shares used in the calculations is as follows:
| (Number of shares x 1,000) | June 2023 | June 2022 |
|---|---|---|
| Weighted average number of ordinary shares | 72,966 | 72,860 |
| Effect of warrants and stock options | - | 40 |
| Weighted average number of ordinary shares (diluted) | 72,966 | 72,901 |
On 30 June 2023, the capital represented 73,228,904 shares, of which 103,627 are treasury shares held by Fagron NV.
A non-recurring item is an event or transaction that is considered abnormal, not related to ordinary company activities, and unlikely to recur in the foreseeable future. This can be a gain or a loss. The total non-recurring profit included in EBITDA amounts to -0.5 million euros (June 2022: -0.8 million euros). Which mainly included legal costs and restructuring costs. In 2022 non-recurring costs mainly included acquisition costs, restructuring costs and a release of contingent consideration related to acquisitions in North America.
Fagron's divisional structure is tailored to the various activities of Fagron and supports also effective decisionmaking and individual responsibility. This is in accordance with IFRS 8, which states that the operational segments must be determined based on the components used by the Executive Leadership Team to assess the performance of the operational activities and on which the decisions are based. Fagron reports according to the following segments: Fagron EMEA, Fagron North America, and Fagron Latin America.
The segment results for the reporting period ending 30 June 2023 are as follows:
| (x 1,000 euros) | Fagron EMEA |
Fagron North America |
Fagron Latin America |
Total |
|---|---|---|---|---|
| Revenue | 146,084 | 145,039 | 80,450 | 371,573 |
| Intersegment revenue | 646 | 80 | 82 | 809 |
| Total revenue | 146,730 | 145,119 | 80,532 | 372,381 |
| Operating profit per segment | 25,652 | 18,326 | 8,750 | 52,728 |
| Financial result | -10,546 | |||
| Profit before income tax | 42,182 | |||
| Taxes | 8,901 | |||
| Net profit (loss) | 33,282 |
The segment results for the reporting period ending 30 June 2022 are as follows:
| (x 1,000 euros) | Fagron EMEA |
Fagron North America |
Fagron Latin America |
Total |
|---|---|---|---|---|
| Revenue | 137,709 | 112,294 | 78,561 | 328,565 |
| Intersegment revenue | 553 | 81 | 154 | 789 |
| Total revenue | 138,263 | 112,375 | 78,715 | 329,353 |
| Operating profit per segment | 22,245 | 14,216 | 10,340 | 46,801 |
| Financial result | -2,186 | |||
| Profit before income tax | 44,615 | |||
| Taxes | 9,317 | |||
| Net profit (loss) | 35,299 |
A detailed explanation of the segment profit and disaggregated revenue are provided in the press release of 3 August 2023.
| (x 1,000 euros) | Fagron EMEA |
Fagron North America |
Fagron Latin America |
Unallocated /inter segment elimination |
Total |
|---|---|---|---|---|---|
| Total assets | 400,255 | 324,155 | 220,720 | 79,589 | 1,024,719 |
| Total liabilities | 148,296 | 216,941 | 52,612 | 166,343 | 584,192 |
| Capital expenditure | 9,524 | 10,395 | 2,823 | 22,742 |
On 30 June 2023, the assets and liabilities, as well as the capital expenditures (investments) are as follows:
On 31 December 2022, the assets and liabilities, as well as the capital expenditures (investments) are as follows:
| (x 1,000 euros) | Fagron EMEA |
Fagron North America |
Fagron Latin America |
Unallocated /inter segment elimination |
Total |
|---|---|---|---|---|---|
| Total assets | 389,344 | 317,010 | 206,270 | 58,387 | 971,010 |
| Total liabilities | 142,593 | 215,830 | 52,487 | 149,583 | 560,493 |
| Capital expenditure | 8,266 | 6,920 | 5,291 | 0 | 20,477 |
Gross capital expenditures in the first half of 2023 mainly relate to investments in registration and exclusive distribution and licensing rights in the Benelux of some products, investments in the Tampa facility in the United States and further software implementations. The investment expenditure excludes the change in investment obligations. The unallocated assets mainly relate to cash and cash equivalents. The unallocated liabilities mainly relate to financial debts.
The increase in goodwill is explained by business combinations as further explained in note 18 and exchange rate differences mainly caused by a weakening of the US dollar and a strengthening of the Brazilian real against the euro as per 31 December 2022.
On 30 June 2023, the outstanding amount of both term loans was a total of 235 million euros (December 2022: 235 million euros) and an amount of 110.4 million euros has been drawn under the syndicated credit line (December 2022: 112.5 million euros).
During the first six months of 2023 no changes have been made to the interest hedge portfolio. The interest rate risk related to 180 million euros of term loans was hedged with interest derivatives. The duration of the euro interest hedges varies from August 2023 until August 2025. The interest hedge related to the interest exposure on 100 million US dollars has remained unchanged and has an end date of June 2024.
All financial instruments are valued at amortised cost except for derivative financial instruments and contingent considerations for acquisitions, which are valued at fair value. The fair value approximates the carrying amount. The interest hedge for 180 million euro related to the long term debt is accounted for under the IFRS hedge accounting rules, resulting in (re-)valuation through equity.
The (re-)valuation of the financial derivatives through the financial result was 1.4 million euros in financial costs (June 2022: 4.2 million euros financial income) from interest rate derivatives and 2.0 million euros (June 2022: 2.2 million euros) in financial costs from currency derivatives. The 2.0 million euros in financial costs due to the
(re-)valuation of the currency derivatives are largely offset by income from exchange rate differences. The remaining increase in the financial expenses mainly relate to higher interest expenses.
On 30 June 2023, the net financial debt / EBITDA ratio equals 1.88 The EBITDA / net interest expense ratio is equal to 7.58. Fagron thus more than met the financial covenants.
Fagron faces certain risks for which no provision has been made because it is unlikely that these risks will have a negative impact for Fagron. In July 2018 and August 2021, Fagron received a tax assessment regarding the amortization of goodwill due to mergers in Brazil. The tax authorities opened a new assessment in April 2023. We dispute these assessments in the total amount of 32.8 million euros and have not made any provision for this purpose. There were no other material changes.
| (x 1,000 euros) | June 2023 | June 2022 |
|---|---|---|
| Amortisation of intangible fixed assets | 5,348 | 4,370 |
| Depreciation of property, plant and equipment | 5,618 | 4,996 |
| Depreciation of lease and similar rights | 5,566 | 4,970 |
| Write down on inventories and receivables | 2,425 | 1,385 |
| Profit (Loss) on sale of fixed assets | -141 | -651 |
| Movements in provisions | 9 | -10 |
| Share-based payments | 1,232 | 1,079 |
| Total adjustments for non-cash items | 20,058 | 16,139 |
| (x 1,000 euros) | June 2023 | June 2022 |
|---|---|---|
| Changes in operational working capital | -14,119 | -14,116 |
| Changes in other working capital | -4,203 | -1,506 |
| Total changes in working capital | -18,322 | -15,662 |
The provisional determination of the fair value of assets acquired and liabilities assumed in the Wildlife Pharmaceutical acquisition in South Africa resulted in an adjustment of 4.0 million euros to goodwill.
The final determination of the fair value of assets acquired and liabilities assumed from prior acquisitions in 2022 resulted in an adjustment of 0.5 million euros to goodwill.
On 30 June 2023, Fagron had 5.5 million euros in contingencies. These fees payable to former shareholders were determined based on business plans at the time of acquisition.
The deferred payments and contingent considerations for business combinations relate to acquisitions in the Netherlands, Germany and South-Africa and vary between 0 euros and a maximum of 5.5 million euros. It is expected that these will be paid in 2023 and 2024.
The considerations are measured at the fair value at acquisition date. This is estimated based on the maximum compensation if the conditions are met.
The members of the Executive Leadership Team and the non-executive directors are considered as related parties. The remuneration policy is described in the Corporate Governance Statement which is part of the 2022 annual report and the Remuneration policy directors and executive leadership team available on www.fagron.com. The remuneration is determined on a yearly basis; therefore, no further details are provided in these interim financial statements.
In the first half of 2023, 138,372 performance shares and 134,271 performance share units were granted to Fagron's executive leadership team and employees. The performance objectives are based on a combination of financial objectives and sustainability objectives. Financial objectives for the first grant under the plan for 2022- 2024 relate to relative total shareholder return (TSR), organic revenue growth, REBITDA, and operational cash conversion. Sustainability objectives for the first grant under the plan for the period 2022-2024, relate to the reduction of greenhouse gas intensity and employee engagement.
In July 2023, a change has been made to the interest hedge portfolio. The interest rate risk related to 20 million euros of term loans was hedged with an interest derivative. The duration of the euro interest hedge is 3 year until August 2026 and replaces an interest derivative of 30 million euros with a duration date till August 2023.
Recognised income tax expenses are based on management's best estimate of the weighted average effective income tax rate of 21.1% for 2023 (S1 2022: 20.9%).
In addition to the performance measures defined in IFRS, other measures are also used in these interim financial statements. These "alternative performance measures" are set out below:
| (x 1,000 euros) | June 2023 | June 2022 |
|---|---|---|
| Operating profit (EBIT) | 52,728 | 46,801 |
| Depreciation and amortization | 18,958 | 15,720 |
| EBITDA | 71,686 | 62,522 |
| EBITDA | 71,686 | 62,522 |
| Non-recurring profit | 497 | 800 |
| REBITDA | 72,183 | 63,322 |
| (x 1.000 euro) | ||
| Total cash flow from operating activities | 43,275 | 38,587 |
| Capital expenditures | -20,984 | -6,681 |
| Free cash flow | 22,291 | 31,906 |
| (x 1,000 euros) | June 2023 | December 2022 |
|---|---|---|
| Net financial debt | ||
| Debt- non-current | 344,509 | 346,673 |
| Lease liabilities - non-current | 31,266 | 33,697 |
| Debt- current | 11 | 9,461 |
| Lease liabilities - current | 9,712 | 9,548 |
| Cash and cash equivalents | 112,213 | 125,337 |
| Total net financial debt | 273,285 | 274,042 |
| Inventories | 127,161 | 108,337 |
| Trade receivables | 76,965 | 60,722 |
| Trade payables | -119,318 | -97,856 |
| Operational working capital | 84,809 | 71,203 |
Report on the review of the consolidated interim financial information for the six-month period ended 30 June 2023
The original text of this report is in Dutch
In the context of our appointment as the company's statutory auditor, we report to you on the consolidated interim financial information. This consolidated interim financial information comprises the condensed consolidated statement of financial position as at 30 June 2023, the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated statement of changes in equity and the condensed consolidated statement of cash flows for the period of six months then ended, as well as selective notes 7 to 22.
We have reviewed the consolidated interim financial information of Fagron NV ("the company") and its subsidiaries (jointly "the group"), prepared in accordance with International Accounting Standard (IAS) 34, "Interim Financial Reporting" as adopted by the European Union.
The consolidated condensed statement of financial position shows total assets of 1 024 719 (000) EUR and the consolidated condensed income statement shows a net profit for the period then ended of 33 282 (000) EUR.
The board of directors of the company is responsible for the preparation and fair presentation of the consolidated interim financial information in accordance with IAS 34, "Interim Financial Reporting" as adopted by the European Union. Our responsibility is to express a conclusion on this consolidated interim financial information based on our review.
We conducted our review of the consolidated interim financial information in accordance with International Standard on Review Engagements (ISRE) 2410, "Review of interim financial information performed by the independent auditor of the entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit performed in accordance with the International Standards on Auditing (ISA) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion on the consolidated interim financial information.
Based on our review, nothing has come to our attention that causes us to believe that the consolidated interim financial information of Fagron NV has not been prepared, in all material respects, in accordance with IAS 34, "Interim Financial Reporting" as adopted by the European Union.
Signed at Antwerp.
Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV/SRL Represented by Ine Nuyts
Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV/SRL Registered Office: Gateway building, Luchthaven Brussel Nationaal 1 J, B-1930 Zaventem VAT BE 0429.053.863 - RPR Brussel/RPM Bruxelles - IBAN BE86 5523 2431 0050 - BIC GKCCBEBB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.